TSE:3407Chemicals
Asahi Kasei (TSE:3407) Valuation in Focus After KDIGO Nefecon Win and High-Power Battery Deal
Asahi Kasei (TSE:3407) shares have seen renewed investor focus after two recent developments. Most notably, the company’s Nefecon gained inclusion in the KDIGO 2025 guidelines for IgA nephropathy, which bolsters its presence in the pharmaceutical sector.
See our latest analysis for Asahi Kasei.
Asahi Kasei’s share price momentum has picked up, climbing 9.6% over the last three months as investors reacted positively to both the KDIGO guideline inclusion for Nefecon and the company’s push into...